-
Published06/10/2025
-
Deadline05/11/2025
-
Awarded12/12/2025
-
Today12/05/2026
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Medicinal products containing octreotide, lanreotide and pasireotide
The subject of the public contract is the continuous supply of medicinal products containing octreotide, lanreotide and pasireotide for a period of 4 years according to the current needs of the contracting authority.
https://www.egordion.cz/nabidkaGORDION/profilFNHK
https://www.egordion.cz/nabidkaGORDION/profilFNHK
33642100 - Pituitary, hypothalamic hormones and analogues
33652000 - Antineoplastic and immunomodulating agents
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.